Sinovac
-
{
- All
- News
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
WHO Approves China's Sinovac Covid Vaccine For Emergency Use
The World Health Organization on Tuesday approved the Sinovac Covid-19 vaccine for emergency use -- the second Chinese jab to receive the WHO's green light.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
China's Sinovac Secures $515 Million To Boost Covid Vaccine Production
China's Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.
-
Millions Took This Chinese Vaccine Against Covid. New Study Has Worrying Results.
The vaccine made by Sinovac Biotech Ltd., one of the most widely used in the world, doesn't provide sufficient antibodies to neutralize the omicron variant, said Hong Kong researchers in initial lab findings that may have sweeping consequences for th
-
UK To Recognise Covaxin, No Quarantine For Fully Vaccinated Travellers
Britain said it would recognise COVID-19 vaccines on the World Health Organization's Emergency Use Listing later this month, adding China's Sinovac, Sinopharm and India's Covaxin to the country's approved list of vaccines for inbound travellers.
-
Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines.
-
WHO Experts Recommend 3rd Dose For Over-60s Jabbed With Sinopharm, Sinovac
The WHO's vaccine advisors recommended Monday that people over 60 who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered a third Covid-19 vaccine dose.
-
Covishield, China's Sinovac Approved By Australia Ahead Of Border Opening
Australia recognized China's Sinovac Biotech Ltd. COVID-19 shot and India-made AstraZeneca Plc jabs, paving the way for overseas travelers and fee-paying foreign students who have received those vaccinations to enter the country.
-
South Africa Vaccinates 2,000 Children In Trial Of Chinese Vaccine
South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.
-
Sinovac Vaccine Antibody Levels May Decline In 6 Months, Booster Helps: Study
Antibodies triggered by Sinovac Biotech's COVID-19 vaccine declined below a key threshold from around six months after a second dose for most recipients, but a third shot had a strong booster effect, a lab study showed.
-
Countries Relying On Chinese Vaccines Reporting Covid Surge: Report
Countries like Mongolia, Seychelles and Bahrain had relied on the easily accessible Chinese COVID-19 vaccines to combat the coronavirus pandemic and bring back normalcy. These countries are now battling a surge in infections.
-
WHO Approves China's Sinovac Covid Vaccine For Emergency Use
The World Health Organization on Tuesday approved the Sinovac Covid-19 vaccine for emergency use -- the second Chinese jab to receive the WHO's green light.
-
China's Sinovac Shot Controls Covid In Brazil Town After 75% Covered
A study of a small Brazilian town vaccinated with the shot made by Sinovac Biotech Ltd. showed it can control Covid-19 outbreaks more effectively than expected from clinical testing.
-
Chinese Sinovac Shot Seen As Highly Effective In Study
Sinovac Biotech Ltd.'s vaccine is wiping out Covid-19 among health workers in Indonesia, an encouraging sign for the dozens of developing countries reliant on the controversial Chinese shot, which performed far worse than western vaccines in clinical
-
This Vaccine Cuts By 50% Risk of Symptomatic Covid: Study
Sinovac Biotech Ltd.'s coronavirus vaccine cut in half the risk of developing symptomatic Covid-19 in a key Brazilian study, suggesting two doses of the shot is less potent than some other immunizations designed to tame the ongoing pandemic.
-
China Approves Sinovac Biotech Coronavirus Vaccine For General Public Use
Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
-
Indonesia Approves China's Sinovac Covid Vaccine Amid Rise In Infections
Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide inoculations to stem surging infections and deaths.
-
China's Sinovac Secures $515 Million To Boost Covid Vaccine Production
China's Sinovac Biotech has secured $515 million in funding from a local firm to double production capacity of its coronavirus vaccine, the companies said on Monday, as it expects efficacy data of its experimental shot this month.
